Project Details
Short title | Explore and identify novel biomarkers or signatures to predict disease progression and to stratify divergent phenotypes for patients with primary sclerosing cholangitis (PSC) with and without inflammatory bowel disease (IBD) |
---|---|
Status | Active |
Effective start/end date | 1/07/20 → 30/06/23 |
Funding
- BRISTOL MYERS SQUIBB PHARMACEUTICALS